Olivier Delfour

535 total citations
8 papers, 213 citations indexed

About

Olivier Delfour is a scholar working on Molecular Biology, Infectious Diseases and Virology. According to data from OpenAlex, Olivier Delfour has authored 8 papers receiving a total of 213 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 2 papers in Infectious Diseases and 2 papers in Virology. Recurrent topics in Olivier Delfour's work include RNA modifications and cancer (2 papers), HIV Research and Treatment (2 papers) and HIV/AIDS drug development and treatment (2 papers). Olivier Delfour is often cited by papers focused on RNA modifications and cancer (2 papers), HIV Research and Treatment (2 papers) and HIV/AIDS drug development and treatment (2 papers). Olivier Delfour collaborates with scholars based in France, Sweden and United Kingdom. Olivier Delfour's co-authors include Fabrice Leclerc, David H. Persing, B. Michot, Bernard Michot, Daniel Gautheret, François Major, Jean−Fred Fontaine, Marie Legendre, Amaury Lambert and Emmanuelle Permal and has published in prestigious journals such as Nucleic Acids Research, PLoS ONE and Cancer Research.

In The Last Decade

Olivier Delfour

8 papers receiving 211 citations

Peers

Olivier Delfour

MB

CR

IMMUN

EPIDE

ONCOL

Sanqi An China

Tomoka Nakamura United States

Haijun Zhu China

Josefine Striepen United States

Chun Shen Lim New Zealand

Christopher Bianco United States

Roberta Ragazzini United Kingdom

Sujan Chaudhuri United States

Konstantinos Karagiannis United States

Sookil Tae United States

Sanqi An China

Olivier Delfour

192 ×1.3

MB

81 ×0.9

CR

40 ×1.0

IMMUN

29 ×1.0

EPIDE

45 ×2.3

ONCOL

Citations per year, relative to Olivier Delfour Olivier Delfour (= 1×) peers Sanqi An

Countries citing papers authored by Olivier Delfour

Since Specialization

Citations

This map shows the geographic impact of Olivier Delfour's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Olivier Delfour with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Olivier Delfour more than expected).

Fields of papers citing papers by Olivier Delfour

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Olivier Delfour. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Olivier Delfour. The network helps show where Olivier Delfour may publish in the future.

Co-authorship network of co-authors of Olivier Delfour

This figure shows the co-authorship network connecting the top 25 collaborators of Olivier Delfour. A scholar is included among the top collaborators of Olivier Delfour based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Olivier Delfour. Olivier Delfour is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

8 of 8 papers shown

1.

Cruzalegui, Francisco, Noureddine Loukili, Olivier Delfour, et al.. (2020). Abstract 3372: VISTA interaction with PSGL1, a likely VISTA receptor in tumors, is effectively disrupted by K0401-020 anti-VISTA antibody. Cancer Research. 80(16_Supplement). 3372–3372. 6 indexed citations

2.

Nicot, Florence, Nicolas Jeanne, Stéphanie Raymond, et al.. (2018). Performance comparison of deep sequencing platforms for detecting HIV‐1 variants in the pol gene. Journal of Medical Virology. 90(9). 1486–1492. 4 indexed citations

3.

Gomez‐Roca, Carlos, Elena Garralda, Francisco Cruzalegui, et al.. (2018). First-in-human trial design for W0101: A first-in-class antibody-drug conjugate targeting IGF-1R and identification of the target patient population. Annals of Oncology. 29. viii145–viii146. 1 indexed citations

4.

Raymond, Stéphanie, Florence Nicot, Nicolas Jeanne, et al.. (2017). Performance comparison of next-generation sequencing platforms for determining HIV-1 coreceptor use. Scientific Reports. 7(1). 42215–42215. 9 indexed citations

5.

Mazières, Julien, Olivier Delfour, Isabelle Rouquette, et al.. (2013). Alternative Processing of the U2 Small Nuclear RNA Produces a 19–22nt Fragment with Relevance for the Detection of Non-Small Cell Lung Cancer in Human Serum. PLoS ONE. 8(3). e60134–e60134. 32 indexed citations

6.

Ma, Yuqian, Olivier Delfour, Jonathan Edgeworth, et al.. (2013). Genome-Wide Sequencing of Cellular microRNAs Identifies a Combinatorial Expression Signature Diagnostic of Sepsis. PLoS ONE. 8(10). e75918–e75918. 76 indexed citations

7.

Porcel, Betina M., Olivier Delfour, Vanina Castelli, et al.. (2004). Numerous Novel Annotations of the Human Genome Sequence Supported by a 5′-End–Enriched cDNA Collection. Genome Research. 14(3). 463–471. 13 indexed citations

8.

Lambert, Amaury, Jean−Fred Fontaine, Marie Legendre, et al.. (2004). The ERPIN server: an interface to profile-based RNA motif identification. Nucleic Acids Research. 32(Web Server). W160–W165. 72 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact